MetaCap

iRadimed (IRMD) vs SpyGlass Pharma (SGP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

iRadimed is the larger company by market cap ($1.04 billion vs $1.02 billion), about 1.0 times the size. iRadimed pays a dividend yielding 0.99%, while SpyGlass Pharma does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

IRMD-15.58%SGP+15.27%
+49%+6%-37%
Feb 6, 20261 yearNov 20, 2026
IRMD-15.58%SGP+15.27%
+43%+5%-34%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

IRMD versus SGP key metrics
MetricIRMDSGP
Share price$81.02$30.43
Market cap$1.04B$1.02B
1-day change-0.30%-1.14%
YTD return-16.71%—
1-year return-9.50%—
5-year return+91.58%—
P/E ratio (TTM)43.33—
Forward P/E33.25—
EPS (TTM)$1.87$-2.70
Dividend yield0.99%0.00%
Annual dividend$0.80$0.00
Revenue (latest FY)$83.81M—
Revenue growth (YoY)+14.43%—
Net income (latest FY)$22.48M$-39.87M
Gross margin76.75%—
Operating margin31.20%—
Net margin26.82%—
52-week high$107.90$39.92
52-week low$76.35$17.06
Distance from 52-week high-24.91%-23.77%
Analyst consensusnonestrong_buy
Avg. price target upside+45.64%+53.37%
Average volume120.89K114.63K
Shares outstanding12.79M33.46M
Employees16688
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About iRadimed

IRMD stock →

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.

Health Care · Medical/Dental Instruments · 166 employees

About SpyGlass Pharma

SGP stock →

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Health Care · Medical/Dental Instruments · 88 employees

IRMD vs SGP FAQ

Which is bigger, iRadimed or SpyGlass Pharma?

iRadimed (IRMD) is larger, with a market capitalization of $1.04B compared with $1.02B for SpyGlass Pharma (SGP).

Which pays a higher dividend, iRadimed or SpyGlass Pharma?

iRadimed pays a dividend yielding 0.99%, while SpyGlass Pharma does not currently pay a regular dividend.

Are iRadimed and SpyGlass Pharma in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons